Double Your Money in No Time Flat
If you're looking to double your money, the biotech sector is one of the best hunting grounds that you'll find.
So far this year, for instance, the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) – an ETF that's a great proxy for the sector – has zoomed 28.2%, more than double the 13.59% SPDR S&P 500 Index ETF (NYSEArca: SPY). The IBB gained 31% last year.
And a lot of individual biotech stocks have actually doubled, tripled or more – the Holy-Grail type of gains that high-tech investors crave.
But there's a problem.
You see, not all biotech stocks are created equal.
Medical Miracle: Biotech Duo Is "Printing" New Organs
Imagine a future in which anyone needing a transplant could just create the needed tissue on their home printer.
That day hasn't arrived yet … but it's getting closer all the time.
A partnership between a global software firm and an early-stage biotech player is already promising to transform the field of medical transplants.
And for many patients, that day can't get here soon enough.
Stunning Bionic Advances Mean the Return of the Six Million Dollar Man
As a teen growing up in the 1970s, I was a fan of the popular TV show The Six Million Man, and often dreamed of being a real-life version of Steve Austin, the world's original bionic being.
For millions of us, that dream may soon come true.
Austin, you'll no doubt recall, was the bigger-than-life main character of the long-running drama. The former astronaut was battered in a horrid test-flight crash ("I can't hold her … she's breaking up, she's breaking up!") and was expected to die.
But doctors not only saved Austin's life … they decided they could "rebuild him" by using bionic implants.
And those high-tech devices boosted Austin's speed, strength and vision far beyond human levels.
Now a global research team is reporting great progress in building the first fully functional "bionic man."
Like Steve Austin, the lab-created being – nicknamed "Rex" – has advanced prosthetic limbs. He also has an artificial heart-lung system that pumps synthetic blood. He even has a functional, machine-built pancreas and liver.
Team members say the project shows that, in the very near future, we will be able to give humans a wide range of bionic implants to replace those damaged by disease or trauma.
My colleagues here at Money Map Press know that I'm fond of describing the Era of Radical Change as one in which "science fiction is becoming science fact."
With the case of bionics, that prediction is literally coming true.
For investors, that means this new segment of high-tech/biotech will soon become another subset of the digital realm that's ripe for picking. And when that happens, I'll make sure you're the first to know.
But this engineering marvel isn't the only fascinating piece of technology I came across this month. Take a look…